Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06942949Not ApplicableRecruiting

Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stones, A Pivotal Trial

Role: lead

NCT04563039Not ApplicableCompleted

Acoustic Enhancer Research on Laser Lithotripsy (AEROLITH)

Role: lead

NCT03339388Not ApplicableTerminated

Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stone Disease

Role: lead

NCT03195920Not ApplicableTerminated

Feasibility Study of an Enhanced Lithotripsy System in the Treatment of Urinary Stone Disease

Role: lead

All 4 trials loaded